United Therapeutics UTHR Other — Gross Profit
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's other — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's other — gross profit?
- United Therapeutics (UTHR) reported other — gross profit of -$6.8M in Q1 2026.
- How has United Therapeutics's other — gross profit changed year-over-year?
- United Therapeutics's other — gross profit decreased by 580.0% year-over-year, from -$1M to -$6.8M.
- What does other — gross profit mean?
- This metric represents the profit remaining from the non-core business segments after deducting the direct costs of production from the total revenues generated by those segments. It serves as a key indicator of the underlying profitability and economic viability of the company's secondary business activities. A negative value indicates that the segment is currently operating at a loss before considering broader corporate overheads.